1201644-33-8 Usage
General Description
4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)morpholine is a chemical compound with potential applications in the field of organic synthesis and pharmaceuticals. It contains a heterocyclic ring structure consisting of a morpholine and pyridine moiety, as well as a dioxaborolane group. 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)pyridin-3-yl)morpholine may have significant utility as a building block for the preparation of various organic compounds due to its unique structural features. Its potential use in medicinal chemistry as a precursor for drug development and discovery is also of interest. Additionally, it has been studied for its potential applications in the field of materials science, particularly in the development of novel polymers and functional materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1201644-33-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,6,4 and 4 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1201644-33:
(9*1)+(8*2)+(7*0)+(6*1)+(5*6)+(4*4)+(3*4)+(2*3)+(1*3)=98
98 % 10 = 8
So 1201644-33-8 is a valid CAS Registry Number.
1201644-33-8Relevant articles and documents
NOVEL COMPOUNDS
-
, (2011/07/07)
The present invention relates to novel NADPH oxidase II inhibitors and their use in the treatment of diseases mediated by the NADPH oxidase II enzyme.
